Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...

Automated Microbial Diagnostics

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee.

Journal of substance abuse treatment·2017

Same author

Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration.

Journal of analytical toxicology·2016

Same author

Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration.

Journal of analytical toxicology·2016

Same author

Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.

Journal of analytical toxicology·2015

Same author

Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.

Journal of analytical toxicology·2015

Same author

Risks and responsibilities in prescribing opioids for chronic noncancer pain, part 2: best practices.

Postgraduate medicine·2014

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

Immunoassay in healthcare testing applications.

Anne Z DePriest¹, David L Black², Timothy A Robert³

¹Aegis Sciences Corporation, Nashville, Tennessee; College of Pharmacy, University of Tennessee, Memphis, Tennessee.

Journal of Opioid Management

|March 10, 2015

Summary

Immunoassay drug testing in pain management differs from forensic use. This review covers immunoassay performance for prescription drugs, focusing on opioids and benzodiazepines in clinical settings.

More Related Videos

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

Published on: September 12, 2016

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

Related Experiment Videos

Last Updated: Apr 16, 2026

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

Published on: September 12, 2016

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

Area of Science:

Clinical Chemistry
Toxicology
Pharmacology

Background:

Immunoassay is a common tool for drug testing in pain management.
Clinical drug testing differs from forensic applications, focusing on compliance monitoring with high positivity rates for diverse compounds.
Opioids and benzodiazepines are key drug classes requiring specific immunoassay considerations.

Purpose of the Study:

To review the performance characteristics of immunoassay for drug testing in pain management.
To emphasize the application of immunoassay for prescription drug classes.
To discuss point-of-care testing considerations.

Main Methods:

Literature review of immunoassay performance in clinical drug testing.
Analysis of immunoassay characteristics for opioids and benzodiazepines.
Evaluation of point-of-care testing aspects.

Main Results:

Immunoassay screening in pain management prioritizes detecting a broad range of substances, unlike forensic screening.
Specific challenges exist for immunoassay detection of opioids and benzodiazepines.
Point-of-care testing offers potential benefits but requires careful validation.

Conclusions:

Immunoassay performance for drug testing in pain management necessitates tailored approaches.
Understanding immunoassay limitations and strengths is crucial for accurate clinical monitoring.
Further research on point-of-care immunoassay applications is warranted.